PRIME MD PRIMARY CARE EVALUATION OF MENTAL DISORDERS Trademark Information

Trademark by Pfizer Inc.

printed clinical evaluation guide and patient questionnaire used to diagnose and evaluate mental disorders

Classification Information

Use in Commerce Trademark - Applicant has provided proof of use of this mark in commerce to USPTO.

Primary Class: Class Details:
Class (016)
Paper, cardboard and goods made from these materials, not included in other classes; printed matter; bookbinding material; photographs; stationery; adhesives for stationery or household purposes; artists' materials; paint brushes; typewriters and office requisites (except furniture); instructional and teaching material (except apparatus); plastic materials for packaging (not included in other classes); printers' type; printing blocks.
First Use Anywhere:: 6/12/1992
First Use In Commerce: 6/12/1992
General Information
Word mark: PRIME MD PRIMARY CARE EVALUATION OF MENTAL DISORDERS
Status/Status Date:
CONTINUED USE NOT FILED WITHIN GRACE PERIOD, UN-REVIVABLE
9/17/2005
Serial Number: 74392538
Filing Date: 5/20/1993
Registration Number: 1866951
Registration Date: 12/13/1994
Goods and Services: printed clinical evaluation guide and patient questionnaire used to diagnose and evaluate mental disorders
Mark Description: NOT AVAILABLE
Type Of Mark: TradeMark
Published For Opposition Date: 9/20/1994
Last Applicant/Owner:
Pfizer Inc.
New York 10017
Mark Drawing Code: Drawing/Design + Words(75% Reduction of drawing size)
Design Search:
Incomplete quadrilaterals and quadrilaterals made of broken or dotted lines (Geometric figures and solids - Quadrilaterals) see more design...
Register Type: Principal
Disclaimer: ("PRIMARY CARE EVALUATION OF MENTAL DISORDERS")
Correspondent:
c/o Pfizer Inc.
235 East 42nd Street
New York, NY 10017
Current Status:
CONTINUED USE NOT FILED WITHIN GRACE PERIOD, UN-REVIVABLE
9/17/2005
Correspondent Search:
Arthur A. Silverstein is a correspondent of PRIME MD PRIMARY CARE EVALUATION OF MENTAL DISORDERS trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on